Literature DB >> 16750700

Development of mild aortic valve stenosis in a rabbit model of hypertension.

Luis A Cuniberti1, Pablo G Stutzbach, Eduardo Guevara, Gustavo G Yannarelli, Rubén P Laguens, Roberto R Favaloro.   

Abstract

OBJECTIVES: This study was designed to investigate the association between hypertension and aortic valve stenosis (AVS) in a rabbit model.
BACKGROUND: Degenerative AVS is a prevalent disease in elderly persons. Its molecular mechanisms remain unclear, in part because of the absence of experimental models. Epidemiologic data suggest a link between hypertension and AVS. However, there has been no evidence of a cause-effect relationship.
METHODS: New Zealand White rabbits were divided into two groups: 1) animals (n = 20) instrumented according to one-kidney/one-clip hypertensive model; and 2) control animals (n = 10) sham operated. Echocardiography (S12 MHz) was used to assess aortic valve (AV) morphology and function as well as left ventricular mass at baseline and after two and four months of hypertension.
RESULTS: Blood pressure and left ventricular mass increase were highly significant in the animal model but not in controls at two months, without noticeable AV function abnormalities. After 4 months, however, 14 hypertensive survived animals showed a 14.6% reduction of AV area (0.240 +/- 0.063 cm2 vs. 0.205 +/- 0.060 cm2, p < 0.05), a 19.6% increase of AV thickness (0.056 +/- 0.011 cm vs. 0.067 +/- 0.010 cm, p < 0.001), a 40.4% increase of transvalvular mean gradient (5.35 +/- 2.26 mm Hg vs. 7.51 +/- 3.73 mm Hg, p < 0.05) and a 63.6% increase of transvalvular maximal gradient (10.56 +/- 3.68 mm Hg vs. 17.28 +/- 10.95 mm Hg, p < 0.05). Control animals did not show significant changes.
CONCLUSIONS: We report a novel experimental model of AVS in rabbits that may prove useful in studying the progression of the disease and the efficacy of new treatments. The present findings support the hypothesis of a causal link between hypertension and AVS.

Entities:  

Mesh:

Year:  2006        PMID: 16750700     DOI: 10.1016/j.jacc.2005.12.070

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

Review 2.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

Review 3.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

4.  Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.

Authors:  Doan Tm Ngo; Irene Stafford; Aaron L Sverdlov; Weier Qi; Ronald D Wuttke; Yuan Zhang; Darren J Kelly; Helen Weedon; Malcolm D Smith; Jennifer A Kennedy; John D Horowitz
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 5.  Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease.

Authors:  Alison K Schroer; W David Merryman
Journal:  J Cell Sci       Date:  2015-04-27       Impact factor: 5.285

6.  Inhibition of Aortic Valve Calcification by Local Delivery of Zoledronic Acid-an Experimental Study.

Authors:  Andreas Synetos; Konstantinos Toutouzas; Maria Drakopoulou; Iosif Koutagiar; George Benetos; Rafail Kotronias; Nikolaos Anousakis-Vlachochristou; George Latsios; Antonis Karanasos; George Agrogiannis; Marinos Metaxas; Konstantinos Stathogiannis; Aggelos Papanikolaou; Alexandros Georgakopoulos; Nikoleta Pianou; Eleftherios Tsiamis; Efstratios Patsouris; Apostolos Papalois; Dennis Cokkinos; Constantinos Anagnostopoulos; Dimitrios Tousoulis
Journal:  J Cardiovasc Transl Res       Date:  2018-03-26       Impact factor: 4.132

Review 7.  Aortic valve stenosis and arterial hypertension: a synopsis in 2013.

Authors:  Vasiliki Katsi; Maria Marketou; Manolis S Kallistratos; Thomas Makris; Athanasios J Manolis; Dimitris Tousoulis; Christodoulos Stefanadis; Panos Vardas; Ioannis Kallikazaros
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

8.  Animal models of calcific aortic valve disease.

Authors:  Krista L Sider; Mark C Blaser; Craig A Simmons
Journal:  Int J Inflam       Date:  2011-08-02

9.  Gene Profiling of Aortic Valve Interstitial Cells under Elevated Pressure Conditions: Modulation of Inflammatory Gene Networks.

Authors:  James N Warnock; Bindu Nanduri; Carol A Pregonero Gamez; Juliet Tang; Daniel Koback; William M Muir; Shane C Burgess
Journal:  Int J Inflam       Date:  2011-08-18

10.  Relationship between Calcium-Phosphorus Product and Severity of Valvular Heart Insufficiency in Patients Undergoing Chronic Hemodialysis.

Authors:  Masoumeh Kahnooj; Mohammad Masoomi; Ali Naderinasab; Akram Zaeem; Mehrdad Sheikhvatan
Journal:  J Tehran Heart Cent       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.